Kakakhel Mian Zahid Jan, Rath Shree, Sheraz Maheen, Rathi Diya, Ahmed Raheel
Rehman Medical College, Peshawar, Khyber Pakhtunkhwa, Pakistan.
All India Institute of Medical Sciences, Bhubaneswar, India.
Trop Med Health. 2025 Mar 24;53(1):39. doi: 10.1186/s41182-025-00726-4.
With lymphatic filariasis being a rampant condition in tropical countries, multiple treatment modalities are being explored for their efficacy and practicability of use in low resource settings. Doxycycline, a commonly available drug across the world, has been proposed to improve patient status in those suffering with lymphatic filariasis. In conjunct with hygiene protocols, emerging trials have highlighted the success of doxycycline as an add-on drug. In this letter, we highlight the major findings in recent trials, and the scope of integrating doxycycline into national elimination strategies against filariasis.
由于淋巴丝虫病在热带国家肆虐，人们正在探索多种治疗方法，以评估其在资源匮乏地区使用的有效性和实用性。多西环素是一种在全球普遍可得的药物，已被提议用于改善淋巴丝虫病患者的状况。结合卫生协议，新出现的试验突出了多西环素作为附加药物的成功。在这封信中，我们强调了近期试验的主要发现，以及将多西环素纳入国家丝虫病消除战略的范围。
